Product Details: BPC 157 Arg

BPC-157 Arg is a synthetic pentadecapeptide derived from a partial sequence of a naturally occurring gastric protein. The “Arg” designation indicates that this form of BPC-157 is prepared as the arginine salt, which can improve peptide stability and solubility in laboratory settings.

BPC-157 Arg is widely used in preclinical and in vitro research to investigate cellular signaling, tissue-specific effects, and regulatory pathways under controlled experimental conditions. It is studied for potential effects on cellular proliferation, angiogenesis, and maintenance of structural integrity in experimental models.

Mechanism of Action

In laboratory studies, BPC-157 Arg is believed to interact with molecular signaling pathways involved in tissue-specific regulation. When applied to experimental models, it may influence vascular endothelial signaling, protein synthesis, and intercellular communication pathways.

Preclinical research suggests that BPC-157 Arg may contribute to the stabilization of cellular structures and modulation of enzymatic or signaling activity in localized experimental systems. Observed effects are limited to controlled laboratory environments.

Properties of BPC 157 Arg: 

• Molecular Formula: C₆₂H₉₈N₁₆O₂₂

• Molecular Weight: 1419.5 g/mol

• CAS Number: 137525-51-0

• PubChem CID: 155977614

• Synonyms: Pentadeca Arginate, BPC-157 Arginate Complex, Arginine salt form of BPC-157

Research Applications/Benefits of BPC 157 Arg

Angiogenesis Modulation in Experimental Models:

BPC-157 Arg is studied for its potential to influence angiogenic pathways in preclinical systems. Early findings indicate it may affect the formation and organization of vascular structures within controlled laboratory models.

Tissue Repair and Cellular Maintenance:

In laboratory settings, BPC-157 Arg is used to investigate its potential role in supporting protein synthesis and signaling pathways that maintain cellular organization and tissue structure in experimental models.

Protection Against Experimental Stressors:

BPC-157 Arg is explored for its potential to mitigate cellular stress in preclinical systems. Laboratory studies examine how the peptide may influence stress-response pathways and maintain structural stability under controlled experimental conditions.

Regulation of Biochemical Signaling:

Preclinical research indicates that BPC-157 Arg may modulate signaling cascades associated with local regulatory molecules and growth factors. Observed effects are limited to laboratory and experimental setups.

Why Choose BehemothLabz to Buy BPC 157 Arg

At BehemothLabz, we understand that reliable research depends on consistent, high-quality compounds. That’s why BPC-157 Arg is produced under rigorous laboratory-grade protocols to ensure stability, purity, and reproducibility for all preclinical and in vitro applications.

Every batch undergoes independent third-party verification, providing detailed reports on composition and purity. This commitment allows laboratory teams to design experiments with confidence in the materials they use.

Our fulfillment process is designed for security and precision. From verified ordering systems to carefully managed national and international shipping, BehemothLabz ensures that research materials arrive intact, accurately labeled, and ready for experimental use.

Disclaimer: This information is for educational purposes. We do not allow the human consumption of our products. All our products are sold for laboratory and research experiments. 

References: 

1. Vasireddi, N., Hahamyan, H., Salata, M. J., Karns, M., Calcei, J. G., Voos, J. E., & Apostolakos, J. M. (2025). Emerging use of BPC-157 in Orthopaedic Sports Medicine: A Systematic review. HSS Journal® the Musculoskeletal Journal of Hospital for Special Surgery, 21(4), 485–495. https://doi.org/10.1177/15563316251355551
2. Józwiak, M., Bauer, M., Kamysz, W., & Kleczkowska, P. (2025). Multifunctionality and possible medical application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals, 18(2), 185. https://doi.org/10.3390/ph18020185
3. Japjec, M., Pavlov, K. H., Petrovic, A., Staresinic, M., Sebecic, B., Buljan, M., Vranes, H., Giljanovic, A., Drmic, D., Japjec, M., Prtoric, A., Lovric, E., Vuletic, L. B., Dobric, I., Blagaic, A. B., Skrtic, A., Seiwerth, S., & Predrag, S. (2021). Stable gastric pentadecapeptide BPC 157 as a therapy for the disable myotendinous junctions in rats. Biomedicines, 9(11), 1547. https://doi.org/10.3390/biomedicines9111547